Wound Debridement Products - Global Market Trajectory & Analytics

Global Wound Debridement Products Market to Reach $2.5 Billion by 2027

Amid the COVID-19 crisis, the global market for Wound Debridement Products estimated at US$1.8 Billion in the year 2020, is projected to reach a revised size of US$2.5 Billion by 2027, growing at a CAGR of 5% over the period 2020-2027.

The U. S. Market is Estimated at $486.1 Million, While China is Forecast to Grow at 7.7% CAGR

The Wound Debridement Products market in the U. S. is estimated at US$486.1 Million in the year 2020. China, the world`s second largest economy, is forecast to reach a projected market size of US$520.8 Million by the year 2027 trailing a CAGR of 7.7% over the analysis period 2020 to 2027. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at 2.8% and 4.5% respectively over the 2020-2027 period. Within Europe, Germany is forecast to grow at approximately 3.1% CAGR. We bring years of research experience to this 15th edition of our report. The 125-page report presents concise insights into how the pandemic has impacted production and the buy side for 2020 and 2021. A short-term phased recovery by key geography is also addressed.

Competitors identified in this market include, among others:

• Advanced Medical Solutions Group Plc.
• Coloplast
• Derma Sciences Inc.
• DeRoyal Industries Inc.
• Lohmann & Rauscher GmbH & Co. KG
• MediWound Ltd.
• Medline Industries Inc.
• Misonix Inc.
• Smith & Nephew Plc.
• Welcare Industries SpA
• Zimmer Biomet Holdings Inc.